Sangamo Therapeutics Stock (NASDAQ: SGMO) stock price, news, charts, stock research, profile.
Open | $0.90 |
Close | $0.96 |
Volume / Avg. | 4.84M / 14.26M |
Day Range | $0.87 - $1.00 |
52 Wk Range | 0.29 - 1.48 |
Market Cap | $197.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 8.68% |
Days to Cover | 3.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sangamo Therapeutics (NASDAQ:SGMO) through any online brokerage.
Other companies in Sangamo Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Skye Bioscience (NASDAQ:SKYE), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA) and Galectin Therapeutics (NASDAQ:GALT).
Sangamo Therapeutics has a consensus price target of $4.64.
The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $0.949 last updated September 20, 2024 at 7:55 PM EDT.
There are no upcoming dividends for Sangamo Therapeutics.
Sangamo Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Sangamo Therapeutics.
Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.